Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,273 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The expression profile of functional regulatory T cells, CD4+CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease.
Kamikozuru K, Fukunaga K, Hirota S, Hida N, Ohda Y, Yoshida K, Yokoyama Y, Tozawa K, Kawa K, Iimuro M, Nagase K, Saniabadi AR, Nakamura S, Miwa H, Matsumoto T. Kamikozuru K, et al. Among authors: fukunaga k. Clin Exp Immunol. 2009 May;156(2):320-7. doi: 10.1111/j.1365-2249.2009.03904.x. Epub 2009 Mar 9. Clin Exp Immunol. 2009. PMID: 19292766 Free PMC article.
Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: a 3-year prospective randomized open trial.
Yoshida K, Fukunaga K, Ikeuchi H, Kamikozuru K, Hida N, Ohda Y, Yokoyama Y, Iimuro M, Takeda N, Kato K, Kikuyama R, Nagase K, Hori K, Nakamura S, Miwa H, Matsumoto T. Yoshida K, et al. Among authors: fukunaga k. Inflamm Bowel Dis. 2012 Sep;18(9):1617-23. doi: 10.1002/ibd.21928. Epub 2011 Nov 13. Inflamm Bowel Dis. 2012. PMID: 22081474 Clinical Trial.
Demonstration of low-regulatory CD25High+CD4+ and high-pro-inflammatory CD28-CD4+ T-Cell subsets in patients with ulcerative colitis: modified by selective granulocyte and monocyte adsorption apheresis.
Yokoyama Y, Fukunaga K, Fukuda Y, Tozawa K, Kamikozuru K, Ohnishi K, Kusaka T, Kosaka T, Hida N, Ohda Y, Miwa H, Matsumoto T. Yokoyama Y, et al. Among authors: fukunaga k. Dig Dis Sci. 2007 Oct;52(10):2725-31. doi: 10.1007/s10620-006-9560-z. Epub 2007 Apr 3. Dig Dis Sci. 2007. PMID: 17404876
Cytapheresis as a Non-Pharmacological Therapy for Inflammatory Bowel Disease.
Matsumoto T, Fukunaga K, Kamikozuru K, Tozawa K, Yokoyama Y, Kusaka T, Onishi K, Miwa H, Nakamura S. Matsumoto T, et al. Among authors: fukunaga k. Transfus Med Hemother. 2008;35(1):18-23. doi: 10.1159/000111763. Epub 2007 Dec 21. Transfus Med Hemother. 2008. PMID: 21547106 Free PMC article.
Therapeutic leukocytapheresis for inflammatory bowel disease.
Saniabadi AR, Hanai H, Fukunaga K, Sawada K, Shima C, Bjarnason I, Lofberg R. Saniabadi AR, et al. Among authors: fukunaga k. Transfus Apher Sci. 2007 Oct;37(2):191-200. doi: 10.1016/j.transci.2007.08.003. Epub 2007 Oct 31. Transfus Apher Sci. 2007. PMID: 17974479 Review.
Hyperthermic stimulation of blood increases the immunological effects of granulocyte and monocyte adsorption in vitro: relevance to extracorporeal immunomodulation.
Tozawa K, Fukunaga K, Kamikozuru K, Ohnishi K, Hida N, Ohda Y, Kusaka T, Yoshida K, Jinno Y, Nagase K, Nakamura S, Miwa H, Matsumoto T. Tozawa K, et al. Among authors: fukunaga k. Transfus Apher Sci. 2008 Oct;39(2):129-35. doi: 10.1016/j.transci.2008.07.012. Transfus Apher Sci. 2008. PMID: 18762459
Factors associated with treatment outcome, and long-term prognosis of patients with ulcerative colitis undergoing selective depletion of myeloid lineage leucocytes: a prospective multicenter study.
Yokoyama Y, Watanabe K, Ito H, Nishishita M, Sawada K, Okuyama Y, Okazaki K, Fujii H, Nakase H, Masuda T, Fukunaga K, Andoh A, Nakamura S. Yokoyama Y, et al. Among authors: fukunaga k. Cytotherapy. 2015 May;17(5):680-8. doi: 10.1016/j.jcyt.2015.02.007. Epub 2015 Mar 21. Cytotherapy. 2015. PMID: 25804800 Clinical Trial.
Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA.
Yokoyama Y, Kawai M, Fukunaga K, Kamikozuru K, Nagase K, Nogami K, Kono T, Ohda Y, Iimuro M, Hida N, Nakamura S, Miwa H, Matsumoto T. Yokoyama Y, et al. Among authors: fukunaga k. BMC Gastroenterol. 2013 Feb 12;13:27. doi: 10.1186/1471-230X-13-27. BMC Gastroenterol. 2013. PMID: 23399416 Free PMC article.
1,273 results